Fulgent Genetics, Inc.: shareholders and insiders

FLGTNASDAQHealthcare · Services-Medical Laboratories

Price

$24.78

November 19, 2026Market cap $692M

What Ploutos Investor adds for Fulgent Genetics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 12 fiscal years, from 2014
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 35% since Nov 5, 2026, when the 10-Q these figures come from was filed ($18.66 then, $25.13 on Nov 18, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Oct 28, 2026, from their own Form 4 filings.

22 Form 4s

Bought on the market

–

nobody

Sold on the market

$386.6K

2 people

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $223.5K by 2 people

  • 2025: no buys, sold $163.1K by 2 people
  • 2026: no buys, sold $223.5K by 2 people
  • Oct 26, 2026Hanlin GaoChief Scientific Officer
    Kind
  • Oct 26, 2026Jian XiePresident and COO
    Kind
  • Oct 26, 2026Paul KimCFO and Treasurer
    Kind
  • Sep 2, 2026Hanlin GaoChief Scientific Officer
    Kind
  • Sep 2, 2026Jian XiePresident and COO
    Kind
  • Sep 1, 2026Paul KimCFO and Treasurer
    Kind
  • Sep 1, 2026Ming HsiehChief Executive Officer
    Kind
  • Aug 27, 2026Jian XiePresident and COO
    Kind
  • Aug 27, 2026Hanlin GaoChief Scientific Officer
    Kind
  • Aug 26, 2026Ming HsiehChief Executive Officer
    Kind
  • Aug 26, 2026Paul KimCFO and Treasurer
    Kind
  • Jul 26, 2026Paul KimCFO and Treasurer
    Kind
  • Jul 26, 2026Jian XiePresident and COO
    Kind
  • Jul 26, 2026Hanlin GaoChief Scientific Officer
    Kind
  • Jun 2, 2026Jian XiePresident and COO
    Kind
  • Jun 2, 2026Hanlin GaoChief Scientific Officer
    Kind
  • Jun 1, 2026Paul KimCFO and Treasurer
    Kind
  • Jun 1, 2026Ming HsiehChief Executive Officer
    Kind
  • May 27, 2026Jian XiePresident and COO
    Kind
  • May 27, 2026Hanlin GaoChief Scientific Officer
    Kind
  • May 26, 2026Paul KimCFO and Treasurer
    Kind
  • May 26, 2026Ming HsiehChief Executive Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before May 27, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by FLGT's officers and directors from 2016 up to November 19, 2025, 10 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DMay 27, 2026 Latest filing
  • Ming Hsiehwith 1 more person
    Share of class32.3%
  • Barclays PLCCOMMON-STOCK
    Share of class7.57%
  • BlackRock, Inc.
    Share of class5.90%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Ming Hsieh32.3%From the filing of May 27, 2026

    The Reporting Person holds the shares of Common Stock reported in this Statement for general investment purposes. The Reporting Person may, from time to time, acquire additional, or dispose of, shares of Common Stock or other securities of the Issuer, in the Reporting Person's capacity as Chief Executive Officer and Chairperson of the Board of the Issuer or otherwise, or engage in discussions with the Issuer concerning investments in the Issuer. The Reporting Person intends to review his ownership of Common Stock (including shares of Common Stock held through the Trust) on a continuing basis and, depending upon the price and availability of shares of Common Stock of the Issuer, subsequent…

    From the filing of May 27, 2026
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Integrated Core Strategies (US) LLC3.00%Feb 4, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Jun 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+229%
  • Millennium Mgmt (Englander)
    In the quarter-20%
  • D.E. Shaw
    In the quarter-40%
  • AQR Capital
    In the quarter+136%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 7.63% of its shares outstanding were held short, -4.7% since the report before.

Shares held short
2.13M
7.63%
Since the report before2.24M on Sep 30, 2026
-4.7%
7.4
287.8K
More days to cover thanof 4,578 US-listed companies with enough volume
80%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 903.6K
  • Nov 15, 2023: Shares held short 931.7K
  • Nov 30, 2023: Shares held short 620.4K
  • Dec 15, 2023: Shares held short 649.4K
  • Dec 29, 2023: Shares held short 551.9K
  • Jan 12, 2024: Shares held short 508.2K
  • Jan 31, 2024: Shares held short 469.9K
  • Feb 15, 2024: Shares held short 517.2K
  • Feb 29, 2024: Shares held short 498.4K
  • Mar 15, 2024: Shares held short 611.2K
  • Mar 28, 2024: Shares held short 604.0K
  • Apr 15, 2024: Shares held short 625.4K
  • Apr 30, 2024: Shares held short 682.4K
  • May 15, 2024: Shares held short 704.0K
  • May 31, 2024: Shares held short 720.9K
  • Jun 14, 2024: Shares held short 783.4K
  • Jun 28, 2024: Shares held short 782.1K
  • Jul 15, 2024: Shares held short 784.0K
  • Jul 31, 2024: Shares held short 693.5K
  • Aug 15, 2024: Shares held short 699.3K
  • Aug 30, 2024: Shares held short 732.8K
  • Sep 13, 2024: Shares held short 723.2K
  • Sep 30, 2024: Shares held short 640.1K
  • Oct 15, 2024: Shares held short 676.1K
  • Oct 31, 2024: Shares held short 645.6K
  • Nov 15, 2024: Shares held short 579.0K
  • Nov 29, 2024: Shares held short 748.9K
  • Dec 13, 2024: Shares held short 821.3K
  • Dec 31, 2024: Shares held short 970.6K
  • Jan 15, 2025: Shares held short 1.07M
  • Jan 31, 2025: Shares held short 1.05M
  • Feb 14, 2025: Shares held short 1.30M
  • Feb 28, 2025: Shares held short 1.38M
  • Mar 14, 2025: Shares held short 1.65M
  • Mar 31, 2025: Shares held short 1.52M
  • Apr 15, 2025: Shares held short 1.76M
  • Apr 30, 2025: Shares held short 1.73M
  • May 15, 2025: Shares held short 1.77M
  • May 30, 2025: Shares held short 1.61M
  • Jun 13, 2025: Shares held short 1.65M
  • Jun 30, 2025: Shares held short 1.93M
  • Jul 15, 2025: Shares held short 1.86M
  • Jul 31, 2025: Shares held short 2.09M
  • Aug 15, 2025: Shares held short 2.08M
  • Aug 29, 2025: Shares held short 2.05M
  • Sep 15, 2025: Shares held short 2.12M
  • Sep 30, 2025: Shares held short 1.94M
  • Oct 15, 2025: Shares held short 1.91M
  • Oct 31, 2025: Shares held short 1.87M
  • Nov 14, 2025: Shares held short 1.87M
  • Nov 28, 2025: Shares held short 1.79M
  • Dec 15, 2025: Shares held short 1.76M
  • Dec 31, 2025: Shares held short 1.57M
  • Jan 15, 2026: Shares held short 1.67M
  • Jan 30, 2026: Shares held short 1.69M
  • Feb 13, 2026: Shares held short 1.55M
  • Feb 27, 2026: Shares held short 1.54M
  • Mar 13, 2026: Shares held short 2.14M
  • Mar 31, 2026: Shares held short 2.47M
  • Apr 15, 2026: Shares held short 2.66M
  • Apr 30, 2026: Shares held short 2.50M
  • May 15, 2026: Shares held short 2.72M
  • May 29, 2026: Shares held short 2.80M
  • Jun 15, 2026: Shares held short 2.73M
  • Jun 30, 2026: Shares held short 2.63M
  • Jul 15, 2026: Shares held short 2.75M
  • Jul 31, 2026: Shares held short 2.57M
  • Aug 14, 2026: Shares held short 2.56M
  • Aug 31, 2026: Shares held short 2.37M
  • Sep 15, 2026: Shares held short 2.32M
  • Sep 30, 2026: Shares held short 2.24M
  • Oct 15, 2026: Shares held short 2.13M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading45.6% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 45.6% of the shares in the reported trades were short sales, against 40.6% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
45.6%
The 14 beforeOct 13, 2026 – Oct 30, 2026
40.6%
Change
+5.0 pts
Short sales a dayon average, of 149.9K shares
68.3K
More than atof 3,666 US-listed companies, same days
34%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 30.7%
  • Oct 14, 2026: Short sales 26.6%
  • Oct 15, 2026: Short sales 51.3%
  • Oct 16, 2026: Short sales 38.2%
  • Oct 19, 2026: Short sales 52.3%
  • Oct 20, 2026: Short sales 42.5%
  • Oct 21, 2026: Short sales 24.1%
  • Oct 22, 2026: Short sales 40.6%
  • Oct 23, 2026: Short sales 37.4%
  • Oct 26, 2026: Short sales 53.3%
  • Oct 27, 2026: Short sales 36.3%
  • Oct 28, 2026: Short sales 41.3%
  • Oct 29, 2026: Short sales 46%
  • Oct 30, 2026: Short sales 60.1%
  • Nov 2, 2026: Short sales 55.3%
  • Nov 3, 2026: Short sales 36.1%
  • Nov 4, 2026: Short sales 33.6%
  • Nov 5, 2026: Short sales 50.5%
  • Nov 6, 2026: Short sales 51.4%
  • Nov 9, 2026: Short sales 37.6%
  • Nov 10, 2026: Short sales 26.6%
  • Nov 11, 2026: Short sales 38.4%
  • Nov 12, 2026: Short sales 58.9%
  • Nov 13, 2026: Short sales 46.2%
  • Nov 16, 2026: Short sales 61.3%
  • Nov 17, 2026: Short sales 62.5%
  • Nov 18, 2026: Short sales 43.9%
  • Nov 19, 2026: Short sales 57.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

10.92M Insiders' shares34.96% Of the company
  • Ming HsiehChief Executive Officer
    Directly9.00M
  • Hanlin GaoChief Scientific Officer
    Directly984.5K
  • Jian XiePresident and COO
    Directly576.4K
  • Paul KimCFO and Treasurer
    Directly353.8K

A lower bound: it counts only the 4 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

16 ETFs holding it0.06% The largest weight (IHF)
  • IHFiShares U.S. Healthcare Providers ETF
    Weight in the fund0.06%
  • FNDASchwab Fundamental U.S. Small Company ETF
    Weight in the fund0.03%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.03%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.03%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.01%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%

16 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

142 Managers, Q2 2026$322M Value of their positions
  • Q3 2025: Managers 164
  • Q4 2025: Managers 179
  • Q1 2026: Managers 160
  • Q2 2026: Managers 142

Institutional investors by quarter

The fund managers holding FLGT, quarter by quarter, from Q3 2016 to Q2 2025, 36 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 142 managers held 15.69M shares, worth $322M. During the quarter 21 opened a position, 38 closed one, 40 added and 52 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter-18%
  • Acadian Asset Management
    In the quarter-18%
  • Vanguard Capital Management
    In the quarter-10%
  • Jacobs Levy Equity Management
    In the quarter+119%
  • JPMorgan Chase
    In the quarter+64%
  • Diametric Capital
    In the quarter+93%
  • Ameriprise Financial
    In the quarter+19%
  • Dimensional Fund Advisors
    In the quarter-6.9%
  • Geode Capital Management
    In the quarter-11%
  • State Street
    In the quarter-5.8%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Fulgent Genetics's filings show?

Who buys and sells is one part of Fulgent Genetics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about FLGT's shareholders

Didn't find what you were looking for?

Ask us
Have FLGT's insiders bought or sold?

From May 27, 2026 to Oct 28, 2026 Fulgent Genetics's insiders bought 0 and sold $223.5K of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold FLGT?

5 of the managers we track held the shares on Jun 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $6.6M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.